Correlation Between Werewolf Therapeutics and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Werewolf Therapeutics and Ikena Oncology, you can compare the effects of market volatilities on Werewolf Therapeutics and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and Ikena Oncology.
Diversification Opportunities for Werewolf Therapeutics and Ikena Oncology
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Werewolf and Ikena is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and Ikena Oncology go up and down completely randomly.
Pair Corralation between Werewolf Therapeutics and Ikena Oncology
Given the investment horizon of 90 days Werewolf Therapeutics is expected to generate 1.24 times more return on investment than Ikena Oncology. However, Werewolf Therapeutics is 1.24 times more volatile than Ikena Oncology. It trades about 0.02 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.01 per unit of risk. If you would invest 226.00 in Werewolf Therapeutics on November 1, 2024 and sell it today you would lose (91.50) from holding Werewolf Therapeutics or give up 40.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Werewolf Therapeutics vs. Ikena Oncology
Performance |
| Timeline |
| Werewolf Therapeutics |
| Ikena Oncology |
Werewolf Therapeutics and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Werewolf Therapeutics and Ikena Oncology
The main advantage of trading using opposite Werewolf Therapeutics and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |